Aspirin May Help Protect Against Bile Duct Cancer: Study
People who took it regularly were three times less likely to develop the disease (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 5, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Oncology, Hepatology, News, Source Type: news
Surgical Management of Intrahepatic CholangiocarcinomaSurgical Management of Intrahepatic Cholangiocarcinoma
Learn about new post-surgical options for intrahepatic cholangiocarcinoma treatment including proton beam therapy and updated chemotherapy regimens. Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Aspirin lowers bile duct cancer risk
Regular aspirin use is associated with an approximately threefold reduction in risk for the three major subtypes of cholangiocarcinoma, results of a case-control study indicate.
In a study comparing... (Source: Family Practice News)
Source: Family Practice News - May 3, 2016 Category: Primary Care Source Type: news
Medical News Today: Bile duct cancer risk may be reduced with aspirin use
The risk of bile duct cancer, or cholangiocarcinoma, was reduced by up to 3.6-fold for aspirin users in a new study, providing further evidence of the drug's anticancer effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 2, 2016 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Aspirin may help prevent bile duct cancer
(Wiley) Regular use of aspirin was linked with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma, in a recent study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2016 Category: Global & Universal Source Type: news
Aspirin May Lower Risk for Bile Duct CancerAspirin May Lower Risk for Bile Duct Cancer
Observational data show that low-dose aspirin users have reduced risk for bile duct cancer in all three subtypes of cholangiocarcinoma. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 22, 2016 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
In the Loop: 'This Is Not the Farewell Tour'
Imagine receiving a terminal cancer diagnosis at age 47. Now imagine calling that diagnosis "a gift." That's how Bonnie Dinneen Hedrick describes her diagnosis with stage 3 multifocal intrahepatic cholangiocarcinoma in a recent profile in Rochester Magazine. "My life is the best it's ever been," she tells the magazine — and adds that she doesn't [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 19, 2016 Category: Databases & Libraries Source Type: news
Study: Aspirin use may prevent bile duct cancer
Stephen FellerCLEVELAND, April 19 (UPI) -- Daily aspirin use can reduce risk for bile duct cancer, researchers at the Mayo Clinic report in a recent study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 19, 2016 Category: Consumer Health News Source Type: news
Aspirin use may help prevent bile duct cancer, study finds
Aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma, report scientists at the conclusion of their study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 19, 2016 Category: Science Source Type: news
Aspirin use may help prevent bile duct cancer, Mayo-led study finds
(Mayo Clinic) A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma. The results are published in Hepatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2016 Category: Global & Universal Source Type: news
Aspirin Use May Help Prevent Bile Duct Cancer
ROCHESTER, Minn. — A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma. The results are published in Hepatology. “Our study found that individuals who took aspirin had a more than a two-and-a-half to three-and-a-half-fold lesser [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 18, 2016 Category: Databases & Libraries Source Type: news
IBD Duration Tied to Cholangiocarcinoma RiskIBD Duration Tied to Cholangiocarcinoma Risk
The duration of inflammatory bowel disease (IBD) is associated with an increased risk of cholangiocarcinoma in patients who also have primary sclerosing cholangitis, according to researchers at the Mayo Clinic in Rochester, Minnesota. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 11, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Sharing Mayo Clinic: Outdoorsman Lives Life to the Fullest After Liver Transplant
Being diagnosed with bile duct cancer that eventually necessitated a liver transplant wasn't enough to keep Steve Woodford down for long. A South African native living in Utah, Steve is professional skydiving instructor, backpacker and canyon guide in Zion National Park. He has always lived on the edge with his active outdoors lifestyle. Getting sick [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 9, 2016 Category: Databases & Libraries Source Type: news
Lucy Crossley died 18 months after developing bile duct cancer symptoms
In June, 2013, Lucy Crossley, then 27, from Leeds, suddenly developed a maddening itch all over her body, although she could find no rash or bites. (Source: the Mail online | Health)
Source: the Mail online | Health - February 23, 2016 Category: Consumer Health News Source Type: news
Ablative Radiotherapy in Intrahepatic CholangiocarcinomaAblative Radiotherapy in Intrahepatic Cholangiocarcinoma
Higher doses of radiotherapy may improve local control and overall survival in patients with inoperable intrahepatic cholangiocarcinoma. Journal of Clinical Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 10, 2016 Category: Radiology Tags: Hematology-Oncology Journal Article Source Type: news
